Clinical Social Workers in Norton, VA Accepting Medicare
7 Clinical Social Workers found. Showing 1 - 7
 Susan Gibson Myers, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 18 Seventh St, Park Ave Center, Suite 207, Norton, VA 24273 Phone: 276-679-0162 Fax: 276-679-0164 |
 Michael Ryan Williams, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 18 Seventh St, Park Ave Center, Suite 207, Norton, VA 24273 Phone: 276-679-0162 Fax: 276-679-0164 |
Mrs. Tracie Suzette Hall, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 616 Park Ave Nw, Norton, VA 24273 Phone: 276-679-1045 Fax: 276-679-1047 |
D. Kaye Weitzman, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 18 7th St Nw, Suite207, Norton, VA 24273 Phone: 276-679-0162 Fax: 276-679-0164 |
Russell Henry Williams, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 616 Park Ave Nw, Norton, VA 24273 Phone: 276-679-1045 Fax: 276-679-1047 |
Ms. Amy Nicole Cooke, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 616 Park Ave Nw, Norton, VA 24273 Phone: 276-679-1045 Fax: 276-679-1045 |
Ms. Ladonna Hall, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1024 Park Ave Nw, Norton, VA 24273 Phone: 276-679-1195 Fax: 276-679-2719 |
News Archive
$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier
The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.
MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals
MorphoSys AG announced today that it has received a milestone payment from OncoMed Pharmaceuticals in connection with the FDA acceptance of an IND for a HuCAL-derived, fully human antibody. The antibody OMP-18R5, which targets the Wnt signaling pathway, will be evaluated in a Phase 1 trial in the US in patients with advanced solid tumors.
CHI submits comments to FDA CDRH 510(k) Working Group Preliminary Report and Recommendations
California Healthcare Institute today submitted formal comments to the U.S. Food and Drug Administration (FDA) regarding the Center for Devices and Radiological Health 510(k) Working Group Preliminary Report and Recommendations, which could transform the 510(k) regulatory process for new medical devices, greatly affecting innovation and public health in California. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.
New strategic brand platform shows UPMC as world-class health care organization
UPMC (University of Pittsburgh Medical Center) today unveiled a new strategic brand platform "UPMC: Life Changing Medicine" and logo, unifying its clinical, insurance and international and commercial services activities with one consistent message.
Poll shows growing popularity for health reform law, politicians sound off
"The health-care overhaul gained popularity from May to June, according to a new tracking poll." The poll, conducted by the Kaiser Family Foundation "found that 48 percent of the public had a favorable view of the law in June while 41 percent had an unfavorable opinion." (Kaiser Health News is a program of the foundation.) In May, the tracking poll had found "41 percent favorable to 44 percent unfavorable."
› Verified 9 days ago